| Literature DB >> 26146459 |
Maria Pardos1, Milena Korostenskaja2, Jing Xiang1, Hisako Fujiwara1, Ki H Lee3, Paul S Horn4, Anna Byars1, Jennifer Vannest5, Yingying Wang6, Nat Hemasilpin1, Douglas F Rose1.
Abstract
Objective evaluation of language function is critical for children with intractable epilepsy under consideration for epilepsy surgery. The purpose of this preliminary study was to evaluate word recognition in children with intractable epilepsy by using magnetoencephalography (MEG). Ten children with intractable epilepsy (M/F 6/4, mean ± SD 13.4 ± 2.2 years) were matched on age and sex to healthy controls. Common nouns were presented simultaneously from visual and auditory sensory inputs in "match" and "mismatch" conditions. Neuromagnetic responses M1, M2, M3, M4, and M5 with latencies of ~100 ms, ~150 ms, ~250 ms, ~350 ms, and ~450 ms, respectively, elicited during the "match" condition were identified. Compared to healthy children, epilepsy patients had both significantly delayed latency of the M1 and reduced amplitudes of M3 and M5 responses. These results provide neurophysiologic evidence of altered word recognition in children with intractable epilepsy.Entities:
Mesh:
Year: 2015 PMID: 26146459 PMCID: PMC4469800 DOI: 10.1155/2015/237436
Source DB: PubMed Journal: Behav Neurol ISSN: 0953-4180 Impact factor: 3.342
Characteristics of patients.
| Nr. | Demographics | Diagnosis | Side | Epilepsy onset, years | Epilepsy duration years | Pathology | Average spike frequencyb | Antiepileptic drugsc | Neuropsychological exam | Seizure outcome | F/U duration (mo) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age, y | Sex | DH | Epilepsy focusa | VCI | PRI | WMI | PSI | FSIQ | WJ L-W | WJ Pcomp | Engel's class | ||||||||
| 1 | 13 | F | R | Temporal | L | 6 | 7 | FCD 2A | 17 | Lamotrigine, topiramate, clonazepam | 79 | 94 | 94 | 103 | 88 | 79 | 76 | Class 1 | 24 |
|
| |||||||||||||||||||
| 2 | 14 | F | R | Frontal, temporal | L | 6 | 8 | FCD 1B | 33 | Levetiracetam, ethosuximide, methosuximide | 67 | 82 | 52 | 68 | 60 | 65 | 75 | Class 1 | 28 |
|
| |||||||||||||||||||
| 3 | 15 | M | R | Frontal | L | 13 | 2 | FCD 1A | 38 | Gabapentin, divalproex sodium | 93 | 102 | 80 | 70 | 84 | 113 | 104 | Class 1 | 26 |
|
| |||||||||||||||||||
| 4 | 12 | M | R | Occipital, temporal | L | 7 | 7 | old ische-mic change | 46 | Levetiracetam, oxcarbazepine, zonisamide | 87 | 67 | 65 | 62 | 65 | 101 | 91 | Class 1 | 36 |
|
| |||||||||||||||||||
| 5 | 12 | M | R | Frontal | R | 8 | 4 | FCD 2A | 0 | Topiramate, lamotrigine | 71 | 94 | 50 | 78 | 62 | 87 | 67 | Class 1 | 19 |
|
| |||||||||||||||||||
| 6 | 11 | F | R | Temporal | L | 6 | 5 | FCD 2B | 100 | Levetiracetam, lamotrigine, clonazepam | NT | 98 | 88 | 88 | 85 | 95 | 99 | Class 1 | 15 |
|
| |||||||||||||||||||
| 7 | 14 | M | R | Frontal, parietal, temporal | R | 13 | 1 | NA | 14 | Oxcarbazepine, gabapentin | NT | NT | NT | NT | NT | 89 | 78 | No surgery yet | NA |
|
| |||||||||||||||||||
| 8 | 10 | M | R | Parietal | L | 8 | 2 | FCD 1B | 0 | Levetiracetam, divalproex sodium | 115 | 102 | 102 | 91 | 105 | 107 | 97 | Class 1 | 47 |
|
| |||||||||||||||||||
| 9 | 17 | M | R | Temporal | L | 5 | 8 | FCD 1B | 5 | Levetiracetam | 73 | 73 | 71 | 75 | 68 | 93 | 92 | Class 1 | 19 |
|
| |||||||||||||||||||
| 10 | 16 | F | R | Frontal | L | 7 | 9 | NA | 0 | Lamotrigine, levetiracetam | NT | NT | NT | NT | NT | 105 | 96 | No surgery yet | NA |
|
| |||||||||||||||||||
| M | 13.4 ± 2.2 | 7.9 ± 2.8 | 5.3 ± 2.9 | 25.3 ± 31.2 | 87.4 | 92.7 ± 12.4 | 76.8 ± 19.2 | 78.5 ± 14.2 | 80 | 93.4 ± 14.3 | 87.5 | 26.8 ± 10.4 | |||||||
|
| |||||||||||||||||||
| Min | 10 | 5 | 1 | 0 | 67 | 67 | 50 | 62 | 60 | 65 | 67 | 15 | |||||||
|
| |||||||||||||||||||
| Max | 17 | 13 | 9 | 100 | 115 | 103 | 102 | 103 | 105 | 113 | 104 | 47 | |||||||
F: female; M: male; R: right; L: left; NT: not tested; NA: not applicable; DH: Dominant Hand; FCD: focal cortical dysplasia; VCI: Verbal Comprehension Index; PRI: Perceptual Reasoning Index; PSI: Processing Speed Index; WMI: Working Memory Index; FSIQ: Full Scale IQ; WJ L-W: Letter-Word Identification; and WJ Pcomp: Passage Comprehension.
aA major epilepsy focus is marked with a star ∗.
bNumber of spikes in 40 min of MEG.
cGiven the night before study (at least 12 h).
Figure 1Visual representation of the audio-visual word presentation paradigm. Stimuli were presented simultaneously from visual (screen) and auditory (earphones) sensory inputs in two different condition (1) “match” condition, for which the visually and acoustically presented words were identical, and (2) “mismatch” condition, for which the visually and acoustically presented words were different. The participants were asked to compare visually and acoustically presented words and to press the response button only if they did not match.
Latencies (ms, mean ± SD) of M1–M5 components separately from left and right hemispheres in epilepsy patients and healthy controls.
| M1 | M2 | M3 | M4 | M5 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Left | Right | Left | Right | Left | Right | Left | Right | Left | Right | |
| Epilepsy | 114.1 | 109.74 | 181.7 | 185.6 | 264.0 | 263.6 | 371.5 | 371.5 | 474.2 | 475.4 |
|
| ||||||||||
| Controls | 90.3 | 92.73 | 154.8 | 161.7 | 248.86 | 255.6 | 341.3 | 349.4 | 450.0 | 447.3 |
Figure 2MEG waveform and topographical map of neuromagnetic activation elicited by visual and auditory words. Five major neuromagnetic responses are clearly identified. They are named as M1, M2, M3, M4, and M5. In topographical maps, red color represents the incoming magnetic fields; blue color represents outgoing magnetic fields. Epilepsy patient (top) had delayed latencies of M1 and M2 components as compared with the healthy control subject (bottom). The amplitudes of M3 and M5 magnetic fields were significantly smaller in epilepsy patients than in healthy controls.
Amplitudes (fT, mean ± SD) of M1–M5 components separately from left and right hemispheres in epilepsy patients and healthy controls.
| M1 | M2 | M3 | M4 | M5 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Left | Right | Left | Right | Left | Right | Left | Right | Left | Right | |
| Epilepsy | 350.1 | 317.0 | 422.4 | 339.1 | 362.8 | 377.7 | 293.5 | 330.4 | 230.4 | 266.7 |
|
| ||||||||||
| Controls | 447.7 | 448.3 | 487.5 | 477.1 | 544.6 | 493.3 | 421.5 | 353.6 | 343.4 | 266.7 |
Figure 3Graphic representation of correlation analysis results: (a) relationship between left hemisphere M5 component amplitude and age at epilepsy onset; (b) relationship between right hemisphere M3 component amplitude and Working Memory Index (WMI); (c) relationship between right hemisphere M5 component amplitude and WMI; (d) relationship between right hemisphere M3 component amplitude and Processing Speed Index (PSI). “∗” is indicated trend toward statistical significance; “∗∗” are indicated statistically significant results before applying False Discovery Rate (FDR) procedure for multiple comparisons.